ÂÜÀòÂÒÂ×

Michael Facendola is an experienced finance and operations executive with a strong background in leadership roles across various companies. Currently serving as Chief Operating Officer and Chief Financial Officer at Truveris since July 2015, Michael has previously held the position of Chief Financial Officer at Collective and Epocrates, as well as Chief Financial Officer at Aureon Biosciences. Earlier career experience includes senior roles at Cardinal Health/Advogent Group, Amersham Biosciences, and Arthur Andersen, where Michael developed a robust expertise in financial management and operations. Michael holds a Bachelor's degree in Accounting from the Isenberg School of Management at UMass Amherst, earned in 1999.